NCT06669208View on ClinicalTrials.gov

Trial of an Inactivated Chikungunya Virus Vaccine

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

February 20, 2026

Study Completion Date

February 20, 2026

Conditions
Chikungunya FeverChikungunya VirusChikungunya
Interventions
BIOLOGICAL

HydroVax-005 CHIKV

HydroVax-005 CHIKV vaccine

OTHER

Placebo

NaCl 0.9%, Normal Saline

Trial Locations (1)

27705

Duke University Health System, Durham

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Najit Technologies, Inc.

INDUSTRY

NCT06669208 - Trial of an Inactivated Chikungunya Virus Vaccine | Biotech Hunter | Biotech Hunter